15-48227465-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000560692.5(SLC12A1):​n.3140G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0293 in 375,746 control chromosomes in the GnomAD database, including 727 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.024 ( 209 hom., cov: 32)
Exomes 𝑓: 0.033 ( 518 hom. )

Consequence

SLC12A1
ENST00000560692.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.716

Publications

1 publications found
Variant links:
Genes affected
SLC12A1 (HGNC:10910): (solute carrier family 12 member 1) This gene encodes a kidney-specific sodium-potassium-chloride cotransporter that is expressed on the luminal membrane of renal epithelial cells of the thick ascending limb of Henle's loop and the macula densa. It plays a key role in concentrating urine and accounts for most of the NaCl resorption. It is sensitive to such diuretics as furosemide and bumetanide. Some Bartter-like syndromes result from defects in this gene. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their biological validity in humans has not been experimentally proven.[provided by RefSeq, May 2010]
SLC12A1 Gene-Disease associations (from GenCC):
  • Bartter disease type 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • antenatal Bartter syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.235 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC12A1NM_000338.3 linkc.724+894G>C intron_variant Intron 5 of 26 ENST00000380993.8 NP_000329.2
LOC128966560XR_932204.4 linkn.351C>G non_coding_transcript_exon_variant Exon 3 of 3
SLC12A1NM_001184832.2 linkc.724+291G>C intron_variant Intron 5 of 26 NP_001171761.1
SLC12A1NM_001384136.1 linkc.724+1518G>C intron_variant Intron 5 of 26 NP_001371065.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC12A1ENST00000380993.8 linkc.724+894G>C intron_variant Intron 5 of 26 5 NM_000338.3 ENSP00000370381.3

Frequencies

GnomAD3 genomes
AF:
0.0240
AC:
3644
AN:
152086
Hom.:
209
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0110
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.0492
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.246
Gnomad SAS
AF:
0.0757
Gnomad FIN
AF:
0.0187
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00778
Gnomad OTH
AF:
0.0245
GnomAD4 exome
AF:
0.0329
AC:
7361
AN:
223542
Hom.:
518
Cov.:
0
AF XY:
0.0352
AC XY:
4230
AN XY:
120196
show subpopulations
African (AFR)
AF:
0.0129
AC:
82
AN:
6338
American (AMR)
AF:
0.0593
AC:
597
AN:
10060
Ashkenazi Jewish (ASJ)
AF:
0.00242
AC:
15
AN:
6186
East Asian (EAS)
AF:
0.251
AC:
2818
AN:
11240
South Asian (SAS)
AF:
0.0678
AC:
2235
AN:
32958
European-Finnish (FIN)
AF:
0.0176
AC:
188
AN:
10706
Middle Eastern (MID)
AF:
0.00576
AC:
5
AN:
868
European-Non Finnish (NFE)
AF:
0.00816
AC:
1087
AN:
133210
Other (OTH)
AF:
0.0279
AC:
334
AN:
11976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
304
608
913
1217
1521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0239
AC:
3642
AN:
152204
Hom.:
209
Cov.:
32
AF XY:
0.0267
AC XY:
1989
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0110
AC:
457
AN:
41536
American (AMR)
AF:
0.0491
AC:
750
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3468
East Asian (EAS)
AF:
0.246
AC:
1271
AN:
5164
South Asian (SAS)
AF:
0.0745
AC:
359
AN:
4820
European-Finnish (FIN)
AF:
0.0187
AC:
198
AN:
10590
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00778
AC:
529
AN:
68026
Other (OTH)
AF:
0.0280
AC:
59
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
171
342
513
684
855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00370
Hom.:
1
Bravo
AF:
0.0255

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.12
DANN
Benign
0.60
PhyloP100
-0.72
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16960682; hg19: chr15-48519662; API